Pick 3

Discussion in 'Supernus' started by anonymous, Jun 5, 2019 at 2:18 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I second that.
     

  2. anonymous

    anonymous Guest


    Just a downward hockey stick of happiness since he left ☹️
     
  3. anonymous

    anonymous Guest

    Thirdsies :(
     
  4. anonymous

    anonymous Guest

    Here I sit glancing at the new CVA for Q3 and I still can't locate Oxtellar XR's seizure reduction rates ANYWHERE. What are we suppose to say if a doctor asks for them??? I miss the days when supernus was a fair and balanced company.
     
  5. anonymous

    anonymous Guest

    You must be a day one rep because we have been off the rails for a while now lol. Bring back VV we want VV. Victor if you are reading this you are the only one that can save us at this point please help us
     
  6. anonymous

    anonymous Guest

    If you can’t sell the efficacy data go back to slinging copy machines or car rentals.
     
  7. anonymous

    anonymous Guest

    Oooh good one. Burn.
     
  8. anonymous

    anonymous Guest

    11 positive trials of OXC/OXR makes OXR powerful. Are we selling OXC or OXR in Q3? The SSP's opening isn't clear. Also, I wasn't aware OXR had 11 positive clinical trials. Can we see those please?
     
  9. anonymous

    anonymous Guest

    What a call I had at lunch today, totally smashed it TXR!!! I really wanted to sell OXR but still can't find OXR's seizure reduction in my CVA. Sucks because we have a sick bonus plan for Q3.
     
  10. anonymous

    anonymous Guest

    so excited for POA.
     
  11. anonymous

    anonymous Guest

    Having to “certify” on a script that no one will ever use after this meeting, on products that we have been selling for years is really making me feel like Supernus is just a company I work for not a company that I am part of.
     
  12. anonymous

    anonymous Guest

    Preach it sister